Tuberculosis

  • Your Selections:

Refine Results

date

Tags

If Health Continues To Wane On G8 Agenda, A Serious Void Will Be Left

In this post in the Global Health Governance blog, Jenilee Guebert, director of research for the global health diplomacy program and G8 research group at the University of Toronto’s Munk School of Global Affairs, writes that, “for the second year in a row, the amount of attention devoted to global health” at the annual G8 summit, which took place at Camp David in Maryland in May, has declined. “Global health was not completely absent from the summit,” she continues, highlighting several health initiatives discussed at the meeting, including the New Alliance for Food Security and Nutrition, launched “to accelerate the flow of private capital to African agriculture” with an aim of “lift[ing] 50 million people out of poverty over the next decade.”

Experimental Drug Tested Against Multi-Drug Resistant TB

“Researchers who tested a novel type of antibiotic against multi-drug-resistant tuberculosis [MDR-TB] are reporting that nearly half of patients who got the new drug cleared the bacteria from their lung fluid in two months,” according to a study published Thursday in the New England Journal of Medicine, Reuters reports. Japanese pharmaceutical company Otsuka developed the experimental drug, delamanid, and “also designed and financed the clinical trial, which took place in 17 medical centers across nine countries,” the news service writes (Emery, 6/6).

Panelists Discuss Recent Changes To Global Fund During Kaiser Family Foundation Webcast

During a live webcast discussing recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria, “[p]anelists discussed the fund’s new strategy and what this strategy means for the global fight against these three diseases,” GlobalPost’s “Global Pulse” blog reports. J. Stephen Morrison, senior vice president and director of the Global Health Policy Center at the Center for Strategic and International Studies, noted the Global Fund’s new general manager, Gabriel Jaramillo, had moved quickly in focusing on restructuring and realigning the fund, according to the blog. Todd Summers, independent consultant and chair of the Strategy, Investment & Impact Committee at the Global Fund, said, “Now we see lots of opportunity to really make a big difference and change forever the trajectory” of the epidemics, “Global Pulse” notes.

U.S., Nigeria Inaugurate Defense Reference Laboratory In Abuja

U.S. Ambassador to Nigeria Terence McCulley spoke on Monday in Abuja at the inauguration of a Defense Reference Laboratory, Leadership reports, noting he said the laboratory, “which is the first of its kind in the sub-region,” was supported by U.S. funding. According to the newspaper, McCulley said the Reference Laboratory Program is part of U.S. assistance to Nigeria through a partnership between the U.S. Department of Defense (DOD) and Nigeria’s Ministry of Defense (NMOD) through the Walter Reed Program (WRP-N) and the Emergency Plan Implementation Committee (EPIC), which began in 2005 (8/30).

GeneXpert TB Test Maker Cepheid Signs Deals With PEPFAR, USAID, Others To Provide Lower-Cost Kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports. “The agreements will see the test sold for $9.98, down from its current price of $16.86 per test,” the news service writes, adding, “Cepheid said the Bill & Melinda Gates Foundation will make an initial payment of $3.5 million to make the test immediately available at the lower price” (Ail, 8/6).

New Issue Of ‘Global Fund News Flash’ Available Online

The Global Fund to Fight AIDS, Tuberculosis and Malaria has published Issue 39 of its newsletter, the “Global Fund News Flash.” The issue features an article on the fund’s allocation amounts to countries for 2014-2016 and also features a video giving an overview of the new funding model (3/12).

New Room-Temperature Vaccine Can Be ‘Game-Changer’ In Developing Countries

VOA News: Room-Temperature Vaccine Could Be Boon to Developing Countries “Scientists have developed a revolutionary vaccine that does not require refrigeration or booster shots, making the so-called nanovaccine a potential ‘game-changer’ in curbing disease in the developing world…” (Berman, 3/19).

‘Impatient Optimists’ Blog Publishes TB-Related Posts

The Bill & Melinda Gates Foundation’s “Impatient Optimists” blog published several posts on tuberculosis in recognition of World TB Day on March 24. In one, Mandy Slutsker, a senior project associate for ACTION, summarizes conversations with “advocates and experts from Kenya, Malawi, South Africa, Tanzania, and Zambia on the challenges…

PBS FRONTLINE Film Prompts Media Coverage Of TB Epidemic

News sources examine the growing threat of multidrug-resistant TB, highlighted this week in a FRONTLINE special presentation. PBS FRONTLINE: TB Silent Killer The full-length video report on tuberculosis (TB) is available online, in addition to several accompanying news stories. “From the valleys of Swaziland in Southern Africa, the story of…

Southern African Leaders Agree To Framework To Address TB Among Miners

GlobalPost: Southern African countries commit to address mineworkers’ TB “…To mark World TB Day, ministers from southern Africa met in Johannesburg on Tuesday to develop a regional strategy for reducing TB among mineworkers. Leaders from South Africa, Lesotho, Mozambique and Swaziland — the four countries home to the largest share…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.